Suppr超能文献

西布曲明作为心源性猝死的一个原因。

Sibutramine as a Cause of Sudden Cardiac Death.

作者信息

Rodriguez-Guerra Miguel, Yadav Mayank, Bhandari Manoj, Sinha Archna, Bella Jonathan N, Sklyar Eduard

机构信息

BronxCare Health System, New York, USA.

Icahn School of Medicine at Mount Sinai, New York, USA.

出版信息

Case Rep Cardiol. 2021 Feb 6;2021:8896932. doi: 10.1155/2021/8896932. eCollection 2021.

Abstract

Sibutramine was withdrawn from the US market due to association with adverse cardiovascular outcomes especially with patients having preexisting cardiac disease. However, continued presence of sibutramine in herbal medications is a concern to public safety. We report a case of a patient with no evidence of previous coronary heart disease, who presented with non-ST elevation acute coronary syndrome (NSTE-ACS). Urgent coronary catheterization showed nonobstructive coronaries. However, patient died unexpectedly within 24 hours of admission. The patient denied toxic habits but was taking over-the-counter weight loss herbal supplements. Complete autopsy was performed which showed sibutramine in the toxicology. Patient died due to complications of acute inadvertent intoxication of sibutramine. This is the first case report in literature showing association of sibutramine to sudden cardiac death in patients with no prior cardiac history. The continued presence of sibutramine in some over-the-counter weight loss formulations is a very concerning public health issue.

摘要

西布曲明因与不良心血管事件相关联,尤其是对于已有心脏病的患者,已从美国市场撤出。然而,西布曲明持续存在于草药制剂中,这对公共安全构成了担忧。我们报告一例患者,该患者既往无冠心病证据,表现为非ST段抬高型急性冠状动脉综合征(NSTE-ACS)。紧急冠状动脉导管插入术显示冠状动脉无阻塞。然而,患者在入院后24小时内意外死亡。患者否认有不良嗜好,但正在服用非处方减肥草药补充剂。进行了完整的尸检,毒理学检查显示有毒理学物质西布曲明。患者死于西布曲明急性意外中毒的并发症。这是文献中首例显示西布曲明与无心脏病史患者心源性猝死相关联的病例报告。西布曲明持续存在于一些非处方减肥制剂中是一个非常令人担忧的公共卫生问题。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验